Mutual Fund Quarterly
The country's leading funds the past three months have been
buying medical stocks in the latest reporting periods.
Major medical plays being added by top funds includeQuestcor
),SXC Health Solutions (
),Alexion Pharmaceuticals (
) andCatalyst Health Solutions (
These top-performing stocks each hit 52-week highs in the
latest confirmed uptrend.
On average, health/biotech stocks gained 5.62% in June and
1.84% in the second quarter. The S&P 500 rose 4.07% in June
and fell 2.89% in the second quarter.
Among the 197 industry groups, three medical groups were
ranked among the top 10 as of Tuesday.
A handful of telecom stocks have been grabbing the attention
of the best-performing funds.
Cable giantComcast (
) has been heavily added by top funds such as $81.3 billion
Fidelity Contrafund and $4.4 billion MFS Utility Fund.
Top-performing telecom stock American Tower REIT (AMT) was also
rocking its way up to new highs.
IBD spotted two top-notch funds loading up on SXC Health
Solutions, investing an estimated $3.67 million.
The $41.8 billion Fidelity Growth Company Fund bumped up its
holdings in the latest reporting periods.
The Lisle, Ill.-based firm provides pharmacy benefit
management services and health care IT solutions to the health
SXC recently completed its merger with Catalyst Health
Solutions. The combined company is expected to cover about 25
The stock was already moving in a steady uptrend from a
52-week low in October to mid-April. After news of the merger
with Catalyst Health Solutions, the stock rocketed higher to an
intraday high of 101 on April 20.
After that it traded in a flat base amid the spring market
correction. SXC is currently perched at about 97.
The nation's top funds have been unloading Finance-Property
REIT issues, includingApartment Investment & Management
(AIV),Prologis (PLD) andEssex Property (ESS).
Big household names such asMicrosoft (MSFT),Coca-Cola
(KO),Colgate Palmolive (CL),PepsiCo (PEP) andWal-Mart (WMT) were
also sold by top funds in their latest reporting periods.